person · Reporting owner

Trigg Leslie

Disclosed activity across 5 companies

Tapewire entity: 22212
SEC CIK: 0001304125

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Adaptive Biotechnologies CorpADPT · Entity 1126	Director	March 06, 2023	March 09, 2023
Cardiovascular Systems IncCSII · Entity 114141	Director	November 18, 2016	November 21, 2016
Outset Medical, Inc.OM · Entity 7026	Director · Chair and CEO	August 17, 2026	August 18, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Adaptive Biotechnologies Corp

Report date March 06, 2023 · Filed March 09, 2023

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	25,907	Reported balance After 2023-03-06 transaction · row 1 1 source row Row 1 · 2023-03-06 · Grant · Acquired 14,775 · Balance 25,907
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.46 · Expires 2033-03-06	Direct	23,329	Reported balance After 2023-03-06 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2023-03-06 · Grant · Acquired 23,329 · Balance 23,329 F1: The option will vest in equal monthly installments over one year from March 4, 2023, subject to continued service as a director through such vesting dates.

Filing footnotes · ownership attribution and instrument terms

F1: The option will vest in equal monthly installments over one year from March 4, 2023, subject to continued service as a director through such vesting dates.

Cardiovascular Systems Inc

Report date November 18, 2016 · Filed November 21, 2016

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	14,791	Reported balance After 2016-11-18 transaction · row 1 1 source row Row 1 · 2016-11-18 · Sale · Disposed 7,500 · Balance 14,791 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.75 to $27.03 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Common StockSEC Table I · non-derivative	IndirectBy Trigg Family Trust	2,491	Reported balance Holding disclosure · report date 2016-11-18 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 2,491
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	38,950	Reported balance Holding disclosure · report date 2016-11-18 · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · Balance 38,950 F2: Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment, and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership. F3: Represents the aggregate number of restricted stock units (all previously reported) held by reporting person that are payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	5,949	Reported balance Holding disclosure · report date 2016-11-18 · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · Balance 5,949 F4: Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 1,488 shares on September 30, 2016 and 1,487 shares on each of December 31, 2016, March 31, 2017 and June 30, 2017.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.75 to $27.03 inclusive. The reporting person undertakes to provide Cardiovascular Systems, Inc., any security holder of Cardiovascular Systems, Inc. or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment, and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership.

F3: Represents the aggregate number of restricted stock units (all previously reported) held by reporting person that are payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership.

F4: Each restricted stock unit represents the right to receive a payment from CSI equal in value to the market price per share of CSI common stock on the date of payment and shall be payable in cash or shares of Company common stock beginning six months following the termination of each director's board membership; provided, however, that the restricted stock units vest in quarterly amounts of 1,488 shares on September 30, 2016 and 1,487 shares on each of December 31, 2016, March 31, 2017 and June 30, 2017.

Outset Medical, Inc.

Report date August 17, 2026 · Filed August 18, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	194,597	Reported balance After 2026-08-17 transaction · row 1 1 source row Row 1 · 2026-08-17 · Sale · Disposed 3,437 · Balance 194,597 F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 9,319 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Common StockSEC Table I · non-derivative	IndirectTrigg 2002 Rev Trust	41,666	Reported balance Holding disclosure · report date 2026-08-17 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 41,666
Common StockSEC Table I · non-derivative	IndirectTrigg Family Trust	584	Reported balance Holding disclosure · report date 2026-08-17 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 584

Filing footnotes · ownership attribution and instrument terms

F1: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of an aggregate of 9,319 shares of Common Stock underlying RSUs granted to the reporting person on January 12, 2024 and June 10, 2025. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

ARYA Sciences Acquisition Corp IV

Report date July 31, 2024 · Filed August 01, 2024

Section 16 reporting ended · disclosed 2024-08-01. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class B ordinary sharesSEC Table II · derivative / convertible security	Direct	0	Reported balance After 2024-07-31 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2024-07-31 · Disposition to issuer · Disposed 30,000 · Balance 0 F1: In connection with the Business Combination Agreement, dated February 13, 2024, by and among the Issuer, Adagio Medical Holdings, Inc. (f/k/a Aja HoldCo, Inc.) ("HoldCo"), Aja Merger Sub 1 ("Merger Sub 1"), Aja Merger Sub 2, Inc. ("Merger Sub 2") and Adagio Medical, Inc. ("Adagio") (the transactions contemplated thereby, the "Business Combination"), Merger Sub merged with and into the Issuer and Merger Sub 2 merged with and into Adagio, with each of the Issuer and Adagio becoming a wholly owned subsidiary of HoldCo, and the Reporting Person's ordinary shares of the Issuer were automatically converted into shares of common stock of HoldCo, par value $0.0001 per share, on a one-for-one basis.

Filing footnotes · ownership attribution and instrument terms

F1: In connection with the Business Combination Agreement, dated February 13, 2024, by and among the Issuer, Adagio Medical Holdings, Inc. (f/k/a Aja HoldCo, Inc.) ("HoldCo"), Aja Merger Sub 1 ("Merger Sub 1"), Aja Merger Sub 2, Inc. ("Merger Sub 2") and Adagio Medical, Inc. ("Adagio") (the transactions contemplated thereby, the "Business Combination"), Merger Sub merged with and into the Issuer and Merger Sub 2 merged with and into Adagio, with each of the Issuer and Adagio becoming a wholly owned subsidiary of HoldCo, and the Reporting Person's ordinary shares of the Issuer were automatically converted into shares of common stock of HoldCo, par value $0.0001 per share, on a one-for-one basis.

EXACT SCIENCES CORP

Report date March 23, 2026 · Filed March 23, 2026

Section 16 reporting ended · disclosed 2026-03-23. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Ending reported balance After 2026-03-23 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2026-03-23 · Disposition to issuer · Disposed 3,244 · Balance 13,925 F1: On March 23, 2026, pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 19, 2025, by and among Exact Sciences Corporation, a Delaware corporation (the "Issuer"), Abbott Laboratories, an Illinois corporation ("Parent"), and Badger Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), on the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), issued and outstanding immediately prior to the Effective Time, with certain exceptions, was converted into the right to receive $105.00 in cash, without interest (the "Merger Consideration"). Row 2 · 2026-03-23 · Disposition to issuer · Disposed 13,925 · Balance 0 F2: At the Effective Time, each share of Common Stock subject to vesting, repurchase or other lapse restriction and that was granted under an Issuer stock plan and outstanding as of immediately prior to the Effective Time was deemed to be fully vested and cancelled and converted into the right to receive the Merger Consideration, less any applicable tax withholding.

Filing footnotes · ownership attribution and instrument terms

F1: On March 23, 2026, pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of November 19, 2025, by and among Exact Sciences Corporation, a Delaware corporation (the "Issuer"), Abbott Laboratories, an Illinois corporation ("Parent"), and Badger Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a direct, wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), on the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.01 per share ("Common Stock"), issued and outstanding immediately prior to the Effective Time, with certain exceptions, was converted into the right to receive $105.00 in cash, without interest (the "Merger Consideration").

F2: At the Effective Time, each share of Common Stock subject to vesting, repurchase or other lapse restriction and that was granted under an Issuer stock plan and outstanding as of immediately prior to the Effective Time was deemed to be fully vested and cancelled and converted into the right to receive the Merger Consideration, less any applicable tax withholding.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 03, 2023 Filed May 5, 2023 22:11 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionPerformance Options (right to buy) · Derivative	20,000	$0.00 Strike: $4.11	$0.00	Disclosure SEC source: 0001484612-23-000032 · edgardoc.xml · derivative · entry 9 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,910 Underlying: Common Stock · 20,000 shares Expires 2028-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023. F4 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document
May 03, 2023 Filed May 5, 2023 22:11 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionPerformance Options (right to buy) · Derivative	10,508	$0.00 Strike: $3.88	$0.00	Disclosure SEC source: 0001484612-23-000032 · edgardoc.xml · derivative · entry 8 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,508 shares Expires 2027-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023. F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document
May 03, 2023 Filed May 5, 2023 22:11 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	10,508	$20.00	$210,160.00	Disclosure SEC source: 0001484612-23-000032 · edgardoc.xml · nonDerivative · entry 6 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 412,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023. Read SEC document
May 03, 2023 Filed May 5, 2023 22:11 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionCommon Stock	10,508	$3.88	$40,771.04	Disclosure SEC source: 0001484612-23-000032 · edgardoc.xml · nonDerivative · entry 5 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 422,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023. Read SEC document
May 03, 2023 Filed May 5, 2023 22:11 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	9,492	$20.00	$189,840.00	Disclosure SEC source: 0001484612-23-000032 · edgardoc.xml · nonDerivative · entry 4 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 412,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023. Read SEC document
May 03, 2023 Filed May 5, 2023 22:11 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionCommon Stock	9,492	$4.11	$39,012.12	Disclosure SEC source: 0001484612-23-000032 · edgardoc.xml · nonDerivative · entry 3 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 421,943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023. Read SEC document
May 03, 2023 Filed May 5, 2023 22:11 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	20,000	$20.01	$400,180.00	Disclosure SEC source: 0001484612-23-000032 · edgardoc.xml · nonDerivative · entry 2 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 412,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023. F2 · price: The price reported in Column 4 is a weighted average price. The 20,000 shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $20.00-$20.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
May 03, 2023 Filed May 5, 2023 22:11 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionCommon Stock	20,000	$4.11	$82,200.00	Disclosure SEC source: 0001484612-23-000032 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 432,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b51 Trading Plan adopted by the reporting person on February 23, 2023. Read SEC document
March 06, 2023 Filed Mar 9, 2023 01:05 UTC	Adaptive Biotechnologies Corp ADPT · Entity 1126	GrantStock Option (right to buy) · Derivative	23,329	$0.00 Strike: $8.46	$0.00	Disclosure SEC source: 0001062993-23-006331 · form4.xml · derivative · entry 2 Trigg Leslie · CIK 0001304125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,329 Underlying: Common Stock · 23,329 shares Expires 2033-03-06 F1 · derivative.exercise_date: The option will vest in equal monthly installments over one year from March 4, 2023, subject to continued service as a director through such vesting dates. Read SEC document
March 06, 2023 Filed Mar 9, 2023 01:05 UTC	Adaptive Biotechnologies Corp ADPT · Entity 1126	GrantCommon Stock	14,775	$0.00	$0.00	Disclosure SEC source: 0001062993-23-006331 · form4.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,907 Read SEC document
March 01, 2023 Filed Mar 2, 2023 23:20 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionPerformance Options (right to buy) · Derivative	30,000	$0.00 Strike: $3.88	$0.00	Disclosure SEC source: 0001484612-23-000028 · edgardoc.xml · derivative · entry 4 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,508 Underlying: Common Stock · 30,000 shares Expires 2027-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document
March 01, 2023 Filed Mar 2, 2023 23:20 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	30,000	$22.48	$674,487.00	Disclosure SEC source: 0001484612-23-000028 · edgardoc.xml · nonDerivative · entry 2 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412,451 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $21.00 - $21.99 - 600 shares; $22.00 - $22.99 - 29,400 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. F3 · balance_after: Includes 1,422 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c). Read SEC document
March 01, 2023 Filed Mar 2, 2023 23:20 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionCommon Stock	30,000	$3.88	$116,400.00	Disclosure SEC source: 0001484612-23-000028 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 442,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
February 16, 2023 Filed Feb 17, 2023 01:39 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	2,083	$24.36	$50,741.88	Disclosure SEC source: 0001484612-23-000021 · edgardoc.xml · nonDerivative · entry 2 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,029 F2 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 4,071 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document
February 16, 2023 Filed Feb 17, 2023 01:39 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	932	$24.36	$22,703.52	Disclosure SEC source: 0001484612-23-000021 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,112 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,821 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document
February 01, 2023 Filed Feb 2, 2023 23:41 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionPerformance Options (right to buy) · Derivative	30,000	$0.00 Strike: $3.88	$0.00	Disclosure SEC source: 0001484612-23-000017 · edgardoc.xml · derivative · entry 4 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,508 Underlying: Common Stock · 30,000 shares Expires 2027-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document
February 01, 2023 Filed Feb 2, 2023 23:41 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	30,000	$28.06	$841,779.00	Disclosure SEC source: 0001484612-23-000017 · edgardoc.xml · nonDerivative · entry 2 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,044 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $27.00 - $27.99 - 14,718 shares; $28.00 - $28.99 - 15,282 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. Read SEC document
February 01, 2023 Filed Feb 2, 2023 23:41 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionCommon Stock	30,000	$3.88	$116,400.00	Disclosure SEC source: 0001484612-23-000017 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 444,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
January 27, 2023 Filed Jan 30, 2023 21:46 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	6,281	$27.92	$175,365.52	Disclosure SEC source: 0001484612-23-000014 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,044 F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 16,278 shares of Common Stock underlying RSUs granted to the reporting person on January 26, 2022. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document
January 06, 2023 Filed Jan 9, 2023 21:51 UTC	Outset Medical, Inc. OM · Entity 7026	GrantCommon Stock	23,893	$0.00	$0.00	Disclosure SEC source: 0001484612-23-000003 · edgardoc.xml · nonDerivative · entry 2 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,325 F2 · shares: Represents portion of stock units granted to the reporting person on January 6, 2023 that will vest on December 31, 2025, subject only to the reporting person's continuous service through the vesting date. Each stock unit represents a contingent right to receive one share of common stock. Read SEC document
January 06, 2023 Filed Jan 9, 2023 21:51 UTC	Outset Medical, Inc. OM · Entity 7026	GrantCommon Stock	106,189	$0.00	$0.00	Disclosure SEC source: 0001484612-23-000003 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396,432 F1 · shares: Represents restricted stock units ("RSU") granted to the reporting person on January 6, 2023. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 6, 2024, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date. Read SEC document
January 03, 2023 Filed Jan 4, 2023 22:13 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionPerformance Options (right to buy) · Derivative	30,000	$0.00 Strike: $3.88	$0.00	Disclosure SEC source: 0001484612-23-000001 · edgardoc.xml · derivative · entry 4 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,508 Underlying: Common Stock · 30,000 shares Expires 2027-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document
January 03, 2023 Filed Jan 4, 2023 22:13 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	30,000	$25.26	$757,728.00	Disclosure SEC source: 0001484612-23-000001 · edgardoc.xml · nonDerivative · entry 2 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,243 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $24.00 - $24.99 - 12,402 shares; $25.00 - $25.99 - 14,060 shares; $26.00 - $26.99 - 3,538 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. Read SEC document
January 03, 2023 Filed Jan 4, 2023 22:13 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionCommon Stock	30,000	$3.88	$116,400.00	Disclosure SEC source: 0001484612-23-000001 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,243 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 01, 2022 Filed Dec 2, 2022 23:13 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionPerformance Options (right to buy) · Derivative	21,283	$0.00 Strike: $3.88	$0.00	Disclosure SEC source: 0001484612-22-000082 · edgardoc.xml · derivative · entry 7 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,508 Underlying: Common Stock · 21,283 shares Expires 2027-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document
December 01, 2022 Filed Dec 2, 2022 23:13 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionPerformance Options (right to buy) · Derivative	8,717	$0.00 Strike: $3.88	$0.00	Disclosure SEC source: 0001484612-22-000082 · edgardoc.xml · derivative · entry 6 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,791 Underlying: Common Stock · 8,717 shares Expires 2027-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document
December 01, 2022 Filed Dec 2, 2022 23:13 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	21,283	$20.85	$443,750.55	Disclosure SEC source: 0001484612-22-000082 · edgardoc.xml · nonDerivative · entry 4 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,243 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022. Read SEC document
December 01, 2022 Filed Dec 2, 2022 23:13 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionCommon Stock	21,283	$3.88	$82,578.04	Disclosure SEC source: 0001484612-22-000082 · edgardoc.xml · nonDerivative · entry 3 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 311,526 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 01, 2022 Filed Dec 2, 2022 23:13 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	8,717	$20.85	$181,749.45	Disclosure SEC source: 0001484612-22-000082 · edgardoc.xml · nonDerivative · entry 2 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,243 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022. Read SEC document
December 01, 2022 Filed Dec 2, 2022 23:13 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionCommon Stock	8,717	$3.88	$33,821.96	Disclosure SEC source: 0001484612-22-000082 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 298,960 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
November 16, 2022 Filed Nov 17, 2022 21:15 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	916	$19.29	$17,669.64	Disclosure SEC source: 0001484612-22-000074 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 290,243 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,821 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document
November 11, 2022 Filed Nov 15, 2022 00:53 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionPerformance Options (right to buy) · Derivative	30,000	$0.00 Strike: $3.88	$0.00	Disclosure SEC source: 0001484612-22-000070 · edgardoc.xml · derivative · entry 4 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,508 Underlying: Common Stock · 30,000 shares Expires 2027-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document
November 11, 2022 Filed Nov 15, 2022 00:53 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	30,000	$20.00	$600,000.00	Disclosure SEC source: 0001484612-22-000070 · edgardoc.xml · nonDerivative · entry 2 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,159 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022. Read SEC document
November 11, 2022 Filed Nov 15, 2022 00:53 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionCommon Stock	30,000	$3.88	$116,400.00	Disclosure SEC source: 0001484612-22-000070 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,159 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 16, 2022 Filed Aug 16, 2022 22:25 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	914	$21.48	$19,632.72	Disclosure SEC source: 0001484612-22-000066 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 291,159 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,822 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document
August 01, 2022 Filed Aug 2, 2022 21:07 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionPerformance Options (right to buy) · Derivative	30,000	$0.00 Strike: $3.88	$0.00	Disclosure SEC source: 0001484612-22-000059 · edgardoc.xml · derivative · entry 4 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,508 Underlying: Common Stock · 30,000 shares Expires 2027-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document
August 01, 2022 Filed Aug 2, 2022 21:07 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	30,000	$20.00	$600,000.00	Disclosure SEC source: 0001484612-22-000059 · edgardoc.xml · nonDerivative · entry 2 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,073 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2022. Read SEC document
August 01, 2022 Filed Aug 2, 2022 21:07 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionCommon Stock	30,000	$3.88	$116,400.00	Disclosure SEC source: 0001484612-22-000059 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,073 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
June 01, 2022 Filed Jun 2, 2022 20:30 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionPerformance Options (right to buy) · Derivative	14,289	$0.00 Strike: $3.88	$0.00	Disclosure SEC source: 0001484612-22-000055 · edgardoc.xml · derivative · entry 7 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,508 Underlying: Common Stock · 14,289 shares Expires 2027-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested. Read SEC document
June 01, 2022 Filed Jun 2, 2022 20:30 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative	15,711	$0.00 Strike: $3.88	$0.00	Disclosure SEC source: 0001484612-22-000055 · edgardoc.xml · derivative · entry 6 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,711 shares Expires 2027-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vested in 48 equal monthly installments beginning on October 19, 2017. Read SEC document
June 01, 2022 Filed Jun 2, 2022 20:30 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	15,711	$20.95	$329,093.60	Disclosure SEC source: 0001484612-22-000055 · edgardoc.xml · nonDerivative · entry 4 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,073 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2,2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $20.00-$21.99 - 17,954 shares; $21.00-$22.99 - 11,446 shares; $23.00-$23.99 - 600 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
June 01, 2022 Filed Jun 2, 2022 20:30 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionCommon Stock	15,711	$3.88	$60,958.68	Disclosure SEC source: 0001484612-22-000055 · edgardoc.xml · nonDerivative · entry 3 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,784 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
June 01, 2022 Filed Jun 2, 2022 20:30 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	14,289	$20.95	$299,307.40	Disclosure SEC source: 0001484612-22-000055 · edgardoc.xml · nonDerivative · entry 2 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,073 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2,2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $20.00-$21.99 - 17,954 shares; $21.00-$22.99 - 11,446 shares; $23.00-$23.99 - 600 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
June 01, 2022 Filed Jun 2, 2022 20:30 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionCommon Stock	14,289	$3.88	$55,441.32	Disclosure SEC source: 0001484612-22-000055 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 17, 2022 Filed May 17, 2022 23:03 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	909	$26.36	$23,961.24	Disclosure SEC source: 0001484612-22-000041 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,073 F1 · shares: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of 1,821 shares of Common Stock underlying RSUs granted to the reporting person on March 15, 2021. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document
May 02, 2022 Filed May 3, 2022 20:59 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative	30,000	$0.00 Strike: $3.88	$0.00	Disclosure SEC source: 0001484612-22-000035 · edgardoc.xml · derivative · entry 4 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,711 Underlying: Common Stock · 30,000 shares Expires 2027-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option vested in 48 equal monthly installments beginning on October 19, 2017. Read SEC document
May 02, 2022 Filed May 3, 2022 20:59 UTC	Outset Medical, Inc. OM · Entity 7026	SaleCommon Stock	30,000	$35.87	$1,076,235.00	Disclosure SEC source: 0001484612-22-000035 · edgardoc.xml · nonDerivative · entry 2 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,982 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2,2022. F2 · price: The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $34.00-$34.99 - 1,939 shares; $35.00-$35.99 - 17,182 shares; $36.00-$36.99 - 10,879 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
May 02, 2022 Filed May 3, 2022 20:59 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionCommon Stock	30,000	$3.88	$116,400.00	Disclosure SEC source: 0001484612-22-000035 · edgardoc.xml · nonDerivative · entry 1 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,982 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
April 01, 2022 Filed Apr 4, 2022 21:10 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative	20,000	$0.00 Strike: $4.11	$0.00	Disclosure SEC source: 0001484612-22-000029 · edgardoc.xml · derivative · entry 8 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,365 Underlying: Common Stock · 20,000 shares Expires 2028-11-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option vests in 48 equal monthly installments beginning on December 3, 2018, subject to the reporting person's continued employment through the applicable vesting date. Read SEC document
April 01, 2022 Filed Apr 4, 2022 21:10 UTC	Outset Medical, Inc. OM · Entity 7026	Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative	30,000	$0.00 Strike: $3.88	$0.00	Disclosure SEC source: 0001484612-22-000029 · edgardoc.xml · derivative · entry 7 Trigg Leslie · CIK 0001304125 · Director · Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,711 Underlying: Common Stock · 30,000 shares Expires 2027-09-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option vested in 48 equal monthly installments beginning on October 19, 2017. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.